📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Drug delivery, biodistribution and anti-EGFR activity: theragnostic nanoparticles for simultaneous in vivo delivery of tyrosine kinase inhibitors and kinase activity biosensors. (2021)

First Author: Bofinger R

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/d1nr02770k

PubMed Identifier: 34730152

Publication URI: http://europepmc.org/abstract/MED/34730152

Type: Journal Article/Review

Volume: 13

Parent Publication: Nanoscale

Issue: 44

ISSN: 2040-3364